ISMP Warns of Errors Involving “Depo”-Style Injection Drugs
The ISMP warns of frequent medication errors between Depo-style injection drugs, such as Depo-Provera, Depo-Testosterone and Depo-Medrol which have resulted in adverse events for patients.
The ISMP warns of frequent medication errors between Depo-style injection drugs, such as Depo-Provera, Depo-Testosterone and Depo-Medrol which have resulted in adverse events for patients.
A federal judge has ruled that plaintiffs can continue to pursue off-label marketing claims against generic testosterone drug manufacturers, even though failure to warn claims are preempted.
Heart attack and stroke lawsuits filed against the makers of generic testosterone drugs have been dismissed on preemption grounds, including claims against Depo-Testosterone and Testopel, which some plaintiffs argue are…
The findings of a new study indicate no link between testosterone drugs and cardiovascular risks, adding to the conflicting number of studies over the safety of the popular men's medications.
An investigative report has found that doctors paid by pharmaceutical companies are using educational courses to promote heavier use of testosterone drugs.
Testosterone manufacturers face more than 2,700 lawsuits over claims of heart attacks, strokes and sudden death in federal courts, and a judge has ordered AbbVie to provide clinical trial and…
The U.S. District Judge presiding over the federal testosterone therapy litigation has re-appointed a group of plaintiffs' lawyers to continue serving in leadership roles in the MDL, as a number…
Some types of testosterone replacement therapy may put men more at risk of heart attack than others, according to the findings of a new study.
A status conference will be held today before the U.S. District Judge presiding over nearly 2,000 testosterone drug lawsuits.
A new study finds that high levels of testosterone correlate with larger prostates, with researchers finding implications in the use of low-T drugs.